Fadini, G P http://orcid.org/0000-0002-6510-2097
,
Solini, A
Manca, M L
Zatti, G
Karamouzis, I
Di Benedetto, A
Frittitta, L
Avogaro, A
Funding for this research was provided by:
Società Italiana di Diabetologia (DARWIN-T2D)
Article History
Received: 21 May 2018
Accepted: 17 July 2018
First Online: 9 August 2018
Compliance with ethical standards
:
: GPF received Grant support, lecture or advisory board fees from AstraZeneca, Boehringer-Ingelheim, Eli Lilly, NovoNordisk, Sanofi, Genzyme, Abbott, Novartis, Merck Sharp and Dohme. AS received research Grants from Astra Zeneca and served as advisory board member for Boehringer-Ingelheim and Eli-Lilly. ADB received research grants from NovoNordisk and AstraZeneca, and lecture fees from Boehringer-Ingelheim, Eli-Lilly, Sanofi, Lifescan, Menarini diagnostics. LF received research grant from Therascience, lecture or advisory board fees from Eli-Lilly, Novo-Nordisk, Takeda, AstraZeneca. AA received research grants, lecture or advisory board fees from Merck Sharp and Dome, AstraZeneca, Novartis, Boeringher-Ingelheim, Sanofi, Mediolanum, Janssen, NovoNordisk. GZ, MLM and IK declare no conflict of interest.
: The study was approved by ethical committees of participanting Centers and it was conducted in accordance with the ethical standards of the 1964 Declaration of Helsinki.
: In agreement with National regulations on data protection and privacy, no informed consent was collected because the database was anonymous.